Reuters logo
BRIEF-Actelion's Ledaga wins positive CHMP opinion for skin cancer type
December 16, 2016 / 12:33 PM / 9 months ago

BRIEF-Actelion's Ledaga wins positive CHMP opinion for skin cancer type

Dec 16 (Reuters) - Actelion Ltd

* Actelion receives positive chmp opinion for chlormethine gel (ledaga) for the treatment of mf-ctcl Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below